• APEX2 Regulates TERT Expression in Human Embryonic Stem Cell

  2026-07-07

  This study uncovers a previously unrecognized role for APEX2 in supporting efficient TERT gene expression in human embryonic stem cells. The findings link DNA repair machinery with telomerase regulation, offering new insight into stem cell maintenance, aging, and cancer biology.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Surfac

  2026-07-06

  Sulfo-NHS-Biotin offers unmatched selectivity for cell surface protein labeling, facilitating high-resolution affinity capture and robust downstream applications. Its water solubility and membrane-impermeant chemistry streamline workflows for researchers seeking reproducible, quantitative results in both established and cutting-edge protein interaction studies.

• Meropenem Trihydrate: Mechanistic Insights and Metabolomics

  2026-07-06

  Explore how Meropenem trihydrate advances carbapenem antibiotic research through cutting-edge metabolomics and resistance phenotyping. This article offers an in-depth look at molecular mechanisms, practical protocols, and new diagnostic frontiers.

• Erastin as a Ferroptosis Inducer: Protocols and Tumor Select

  2026-07-05

  Erastin empowers ferroptosis research by enabling precise, iron-dependent cell death in RAS/BRAF-mutant cancer models. This article delivers actionable protocols, troubleshooting tactics, and a translational perspective grounded in the latest glioblastoma research.

• Translational Precision: HyperScript III RT SuperMix in CRC

  2026-07-04

  Explore the mechanistic and strategic role of HyperScript III RT SuperMix for qPCR in advancing immune-focused colorectal cancer (CRC) research. This thought-leadership article integrates bile acid metabolism subtyping, robust biomarker validation, and practical protocol guidance to empower translational teams with actionable insights and optimized workflows.

• Dacarbazine: Optimizing Antineoplastic Chemotherapy Workflow

  2026-07-03

  Dacarbazine stands at the forefront of antineoplastic chemotherapy drug research, enabling nuanced discrimination between cell cycle arrest and cytotoxicity. This guide delivers advanced experimental workflows, troubleshooting tactics, and actionable protocol enhancements to maximize the reliability and translational value of Dacarbazine in cancer studies.

• Ferrostatin-1 (Fer-1): Precision Modulation of Ferroptosis P

  2026-07-03

  Discover how Ferrostatin-1 (Fer-1) enables precise, mechanistic control of ferroptosis in oxidative damage and inflammation models. This cornerstone article reveals unique insights for assay design and translational research in cancer, neurodegeneration, and beyond.

• tFUS Attenuates Stroke Neuroinflammation via Nespas/miR-383-

  2026-07-02

  This study reveals that transcranial focused ultrasound stimulation (tFUS) alleviates neuroinflammation after ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 pathway. The findings provide direct molecular evidence for SHP2’s regulatory role in post-stroke inflammation and clarify the mechanistic basis for tFUS-based interventions.

• TRIM21 Drives ERK1/2-Mediated Proliferation in Pituitary Tum

  2026-07-02

  This study identifies TRIM21 as a pivotal regulator of ERK1/2-mediated cell proliferation and drug resistance in pituitary adenomas. The findings spotlight the potential of targeting TRIM21, notably through epigenetic modulators like Quisinostat, to overcome therapeutic resistance and improve tumor control.

• Hypothalamic SLC7A14 Regulates Age-Related Lipolysis in Mice

  2026-07-01

  This study uncovers the central role of hypothalamic SLC7A14 in mediating age-associated reductions in white adipose tissue (WAT) lipolysis in male mice. By elucidating the molecular and neural pathways connecting the brain, gut, and adipose tissue, the research provides new mechanistic insight into age-related obesity and potential intervention targets.

• SIRT1 Activation by Resveratrol Restores Mitochondrial Bioge

  2026-07-01

  This study demonstrates that SIRT1 activation, particularly via resveratrol, can effectively reverse mitochondrial damage and apoptosis in N2a neuroblastoma cells exposed to the prion protein fragment PrP106–126. By elucidating the PGC-1α–TFAM pathway’s role, these findings identify SIRT1 as a promising target for mitigating mitochondrial dysfunction in prion diseases.

• Supramolecular Chlorogenic Acid-Metal Complexes Suppress Inf

  2026-06-30

  This study demonstrates that supramolecular assemblies of chlorogenic acids with iron and copper exhibit enhanced anti-inflammatory activity by inhibiting the NF-κB pathway and downstream mediators. The findings present a novel strategy for augmenting natural product efficacy in the context of inflammation and signal transduction research.

• Paroxetine Mesylate: Multi-Target SSRI and Kinase Inhibitor

  2026-06-30

  Paroxetine Mesylate is a selective serotonin reuptake inhibitor with high-affinity SERT inhibition and potent multi-kinase activity. Its verified actions include MET and ERBB3 kinase inhibition and significant anti-colorectal cancer effects in vitro and in vivo. This dossier details mechanisms, benchmarks, and protocol considerations for translational research.

• ERAD-Hijacking Chimeras Enable Targeted Degradation of TM Pr

  2026-06-29

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule-based platform that selectively degrades transmembrane proteins by hijacking endoplasmic reticulum-associated degradation (ERAD). This approach overcomes major limitations of existing targeted protein degradation methods, showing high efficacy against challenging membrane targets and expanding opportunities for therapeutic and research applications.

• Breast Cancer’s Reliance on MCL-1: Apoptosis as the Key Func

  2026-06-29

  The referenced study clarifies that breast cancer cell survival is fundamentally dependent on the canonical anti-apoptotic function of MCL-1, rather than its non-apoptotic roles. This finding has practical implications for designing targeted therapies and experimental models using selective MCL-1 inhibitors for apoptosis induction in cancer cells.

449 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page